scholarly article | Q13442814 |
P356 | DOI | 10.1158/1078-0432.CCR-14-1144 |
P698 | PubMed publication ID | 25344580 |
P50 | author | Maryam Fouladi | Q61303209 |
Floyd Gilles | Q88404064 | ||
P2093 | author name string | Shahab Asgharzadeh | |
Mark D Krieger | |||
Girish Dhall | |||
Richard Sposto | |||
Alexander R Judkins | |||
Jonathan L Finlay | |||
Nathan J Robison | |||
Anat Erdreich-Epstein | |||
Ashley S Margol | |||
Long T Hung | |||
Rebekah J Kennedy | |||
Marzieh Vali | |||
Rachid Drissi | |||
Janahan Gnanachandran | |||
P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
Molecular subgroups of medulloblastoma: the current consensus | Q24615271 | ||
Inflammation and cancer | Q24649640 | ||
Cancer-related inflammation | Q27860907 | ||
Ipilimumab plus dacarbazine for previously untreated metastatic melanoma | Q28131634 | ||
Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome | Q28298987 | ||
Subtypes of medulloblastoma have distinct developmental origins | Q28300616 | ||
The genetic landscape of the childhood cancer medulloblastoma | Q28301196 | ||
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis | Q29396371 | ||
Distinct role of macrophages in different tumor microenvironments | Q29614304 | ||
Tumour-educated macrophages promote tumour progression and metastasis | Q29614307 | ||
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm | Q29614349 | ||
Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy | Q29618033 | ||
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features | Q33366431 | ||
Comparison of prognostic gene profiles using qRT-PCR in paraffin samples: a retrospective study in patients with early breast cancer | Q33472698 | ||
A flexible R package for nonnegative matrix factorization | Q33624159 | ||
Tumor-associated macrophages and survival in classic Hodgkin's lymphoma | Q33962334 | ||
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas | Q34167499 | ||
Increased microglia/macrophage gene expression in a subset of adult and pediatric astrocytomas | Q34399073 | ||
Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature. | Q34531618 | ||
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study | Q34606771 | ||
Rapid diagnosis of medulloblastoma molecular subgroups | Q34764793 | ||
CSF-1R inhibition alters macrophage polarization and blocks glioma progression | Q34993852 | ||
Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells | Q35134007 | ||
Differential macrophage programming in the tumor microenvironment | Q35803027 | ||
Environment-mediated drug resistance in Bcr/Abl-positive acute lymphoblastic leukemia | Q36194829 | ||
Definition of Disease-Risk Stratification Groups in Childhood Medulloblastoma Using Combined Clinical, Pathologic, and Molecular Variables | Q36476670 | ||
Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma | Q36910335 | ||
Medulloblastoma comprises four distinct molecular variants | Q36920479 | ||
Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages | Q37209184 | ||
Real-time PCR assay based on the differential expression of microRNAs and protein-coding genes for molecular classification of formalin-fixed paraffin embedded medulloblastomas | Q37312706 | ||
Infiltrating macrophages promote prostate tumorigenesis via modulating androgen receptor-mediated CCL4-STAT3 signaling. | Q37322631 | ||
Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells | Q37385705 | ||
Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. | Q37970302 | ||
The molecular profile of microglia under the influence of glioma | Q38008966 | ||
Microglia and macrophages in malignant gliomas: recent discoveries and implications for promising therapies | Q38122365 | ||
Fc-engineered anti-CD40 antibody enhances multiple effector functions and exhibits potent in vitro and in vivo antitumor activity against hematologic malignancies | Q39682523 | ||
Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations | Q40339027 | ||
The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses | Q41779891 | ||
Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449 | Q42031842 | ||
Glioma grade is associated with the accumulation and activity of cells bearing M2 monocyte markers | Q45735279 | ||
Molecular risk stratification of medulloblastoma patients based on immunohistochemical analysis of MYC, LDHB, and CCNB1 expression | Q46507354 | ||
Transient production of TGF-beta 2 by postnatal cerebellar neurons and its effect on neuroblast proliferation | Q48129225 | ||
Quality of life in children with primitive neuroectodermal tumors (medulloblastoma) of the posterior fossa. | Q52134870 | ||
Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis. | Q55468802 | ||
Tumor-associated macrophages infiltration is associated with peritumoral lymphangiogenesis and poor prognosis in lung adenocarcinoma | Q56607750 | ||
Nuclear localization and mutation of beta-catenin in medulloblastomas | Q73662960 | ||
Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study | Q74299610 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1457-1465 | |
P577 | publication date | 2014-10-24 | |
P1433 | published in | Clinical Cancer Research | Q332253 |
P1476 | title | Tumor-associated macrophages in SHH subgroup of medulloblastomas | |
P478 | volume | 21 |
Q36054158 | BarTeL, a Genetically Versatile, Bioluminescent and Granule Neuron Precursor-Targeted Mouse Model for Medulloblastoma |
Q99237709 | CAR T Cell Therapy for Pediatric Brain Tumors |
Q101410017 | CSF1R inhibition depletes tumor-associated macrophages and attenuates tumor progression in a mouse sonic Hedgehog-Medulloblastoma model |
Q38472322 | Cancer stem cells and tumor-associated macrophages: a roadmap for multitargeting strategies |
Q50437241 | Chemoradiation impairs normal developmental cortical thinning in medulloblastoma. |
Q39795085 | Clinical, Pathological, and Molecular Characterization of Infant Medulloblastomas Treated with Sequential High-Dose Chemotherapy |
Q37040617 | Differential Immune Microenvironments and Response to Immune Checkpoint Blockade among Molecular Subtypes of Murine Medulloblastoma. |
Q35999183 | Disseminated Medulloblastoma in a Child with Germline BRCA2 6174delT Mutation and without Fanconi Anemia |
Q33572502 | Establishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluation. |
Q47101944 | Factors involved in cancer metastasis: a better understanding to "seed and soil" hypothesis |
Q50955504 | Fibrotic focus: An important parameter for accurate prediction of a high level of tumor-associated macrophage infiltration in invasive ductal carcinoma of the breast. |
Q42366544 | Human CAFs promote lymphangiogenesis in ovarian cancer via the Hh-VEGF-C signaling axis |
Q42357972 | Know your neighbors: Different tumor microenvironments have implications in immunotherapeutic targeting strategies across MB subgroups |
Q55221354 | M1 macrophage recruitment correlates with worse outcome in SHH Medulloblastomas. |
Q34552791 | Manipulation of Innate and Adaptive Immunity through Cancer Vaccines. |
Q91596369 | Medulloblastoma |
Q58801546 | Microglia/Astrocytes-Glioblastoma Crosstalk: Crucial Molecular Mechanisms and Microenvironmental Factors |
Q90270316 | Molecular Heterogeneity and Cellular Diversity: Implications for Precision Treatment in Medulloblastoma |
Q36367397 | Molecular subgroups of medulloblastoma identification using noninvasive magnetic resonance spectroscopy. |
Q52714354 | PD-L1 expression in medulloblastoma: an evaluation by subgroup. |
Q33678251 | PID1 increases chemotherapy-induced apoptosis in medulloblastoma and glioblastoma cells in a manner that involves NFκB. |
Q38809641 | Preoperative systemic levels of VEGFA, IL-7, IL-17A, and TNF-β delineate two distinct groups of children with brain tumors |
Q64275194 | Principles of tumorigenesis and emerging molecular drivers of SHH-activated medulloblastomas |
Q52628012 | Role of Macrophages in Brain Tumor Growth and Progression. |
Q92924437 | Sonic Hedgehog Signaling in Organogenesis, Tumors, and Tumor Microenvironments |
Q64004325 | Subgroup-specific immune and stromal microenvironment in medulloblastoma |
Q46745795 | Tumor-associated macrophages promote neuroblastoma via STAT3 phosphorylation and up-regulation of c-MYC. |
Q64939961 | Tumour-associated macrophages exhibit anti-tumoural properties in Sonic Hedgehog medulloblastoma. |
Search more.